VRSN:NASDAQVeriSign, Inc. Analysis
Data as of 2026-08-30 - not real-time
$291.93
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
VeriSign, Inc. is priced at $291.93 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 5.1%. RSI sits at 56.8, which reads as neutral, and MACD momentum is bullish. Watch $271.10 as support and $303.00 as the nearer resistance level.
The shares look undervalued, trading on 32.0 times earnings below a sector average of 35.7. Sell-side targets cluster 8.9% above the current quote. Revenue is growing at 6.0% on a 49.8% profit margin. The 1.11% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 36.2%, a beta of -0.00 and a maximum drawdown of 26.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
The shares look undervalued, trading on 32.0 times earnings below a sector average of 35.7. Sell-side targets cluster 8.9% above the current quote. Revenue is growing at 6.0% on a 49.8% profit margin. The 1.11% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 36.2%, a beta of -0.00 and a maximum drawdown of 26.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.
Top Market Events
Verisign stock trades close to record levels as fresh institutional inflows and a planned .
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 260.75
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 32.0 versus sector average of 35.7
- Trading above the 200-day average of 260.75
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 32.0 versus sector average of 35.7
- Analyst targets imply +8.9% versus the current price
- Profit margin of 49.8% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth6.00%
Profit Margin49.77%
P/E Ratio32.0
ROA45.12%
P/B Ratio-11.7
Op. Cash Flow$1.1B
Free Cash Flow$832.8M
Industry P/E35.7
Technical Analysis
TrendBullish
RSI56.8
Support$271.10
Resistance$303.00
MA 20$287.97
MA 50$275.23
MA 200$260.75
MACDBullish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Fair Value$138.28
Target Price$318.00
Upside/Downside8.93%
GradeUndervalued
TypeBlend
Dividend Yield1.11%
Risk Assessment
Beta-0.00
Volatility36.20%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.